US Drug Recall Register
Class II · Moderate risk Terminated Initiated Aug 10, 2022 (4 years ago)

PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

What was recalled

PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packaged in 30 x 3 mL Sterile Unit-Dose Vials per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th Street Extension, West Columbia, SC 29172; NDC 69374-932-33

Recalling firm
Nephron Sterile Compounding Center LLC
NDC code
69374-932-33
Origin
SC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1344-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Methyl recalls

See all